Expression of Bcl-x(L) and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage

Genes and Development

Volumn 10, Issue 20, 1996, Pages 2621-2631

  Minn, Andy J ^a,b   Boise, Lawrence H ^a   Thompson, Ciaig B ^a,b,c  

^a Gwen Knapp Ctr Lupus Immunol Res   (United States)

^b Cancer Biology and Developmental Biology   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Bcl x(L); checkpoint control; mitosis; mitotic spindle; p53

Indexed keywords

PROTEIN P53; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X;

ANEUPLOIDY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CHROMOSOME SEGREGATION; DNA REPLICATION; GENE EXPRESSION; MITOSIS; MITOSIS SPINDLE; MOUSE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; TETRAPLOIDY; CELL LINE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

APOPTOSIS; BCL-X PROTEIN; CELL CYCLE; CELL LINE; GENE EXPRESSION REGULATION; MITOSIS; MITOTIC SPINDLE APPARATUS; POLYPLOIDY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029658664     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.20.2621     Document Type: Article

References (45)

1. Agarwal, M.L., A. Agarwal, W.R. Taylor, and G.R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. 92: 8493-8497.
2. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608.
3. L. Immunity 3: 87-98.
4. Canman, C.E., T.M. Gilmer, S.B. Coutts, and M.B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Dev. 9: 600-611.
5. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
6. Cox, L.S. and D.P. Lane. 1995. Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage. Bioessays 17: 501-508.
7. Cross, S.M., C.A. Sanchez, C.A. Morgan, M.K. Schimke, S. Ramel, R.L. Idzerda, W.H. Raskind, and B.J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356.
8. Davis, F.M., T.Y. Tsao, S.K. Fowler, and P.N. Rao. 1983. Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. 80: 2926-2930.
9. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
10. Dole, M., G. Nunez, A.K. Merchant, J. Maybaum, C.K. Rode, C.A. Bloch, and V.P. Castle. 1994. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54: 3253-3259.
11. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55: 2576-2582.
12. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
13. Evan, G.I., L. Brown, M. Whyte, and E. Harrington. 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7: 825-834.
14. Fisher, D.E. 1994. Apoptosis in cancer therapy: Crossing the threshold. Cell 78: 539-542.
15. Fukasawa, K., T. Choi, R. Kuriyama, S. Rulong, and G.F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747.
16. Haffner, R. and M. Oren. 1995. Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5: 84-90.
17. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
18. Hartwell, L.H. and M.B. Kastan. 1994. Cell cycle control and cancer. Science 266: 1821-1828.
19. Harvey, M., A.T. Sands, R.S. Weiss, M.E. Hegi, R.W. Wiseman, P. Pantazis, B.C. Giovanella, M.A. Tainsky, A. Bradley, and L.A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467.
20. Hockenbery, D.M. 1995. bcl-2, a novel regulator of cell death. BioEssays 17: 631-638.
21. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
22. Hoyt, M.A., L. Totis, and B.T. Roberts. 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66: 507-517.
23. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
24. Kem, S.E., J.A. Pietenpol, S. Thiagalingam, A. Seymour, K.W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830.
25. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
26. Kung, A.L., S.W. Sherwood, and R.T. Schimke. 1990. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sci. 87: 9553-9557.
27. Li, R. and A.W. Murray. 1991. Feedback control of mitosis in budding yeast. Cell 66: 519-531.
28. Li, X. and R.B. Nicklas. 1995. Mitotic forces control a cell-cycle checkpoint. Nature 373: 630-632.
29. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993a. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967.
30. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993b. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
31. Lowe, S.W., S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, and T. Jacks. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
32. Metz, T., A.W. Harris, and J.M. Adams. 1995. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82: 29-36.
33. L can confer a multidrug resistance phenotype. Blood 86: 1903-1910.
34. Minshull, J., H. Sun, N.K. Tonks, and A.W. Murray. 1994. A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts. Cell 79: 475-486.
35. Miyashita, T. and J.C. Reed. 1993. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157.
36. Murray, A.W. 1994. Cell cycle checkpoints. Curr. Opin. Cell Biol. 6: 872-876.
37. _. 1995. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5: 5-11.
38. Rieder, C.L., R.W. Cole, A. Khodjakov, and G. Sluder. 1995. The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130: 941-948.
39. Sandell, L.L. and V.A. Zakian. 1993. Loss of a yeast telomere: Arrest, recovery, and chromosome loss. Cell 75: 729-739.
40. Schlaifer, D., M. March, S. Krajewski, G. Laurent, J. Pris, G. Delsol, J.C. Reed, and P. Brousset. 1995. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 85: 2671-2674.
41. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12: 5581-5592.
42. Smith, M.L., I.T. Chen, Q. Zhan, I. Bae, C.Y. Chen, T.M. Gilmer, M.B. Kastan, P.M. O'Connor, and A.J. Fornace Jr. 1994. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380.
43. Van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
44. Wang, Y. and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91.
45. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.